Amaranth Medical Inc. is developing a new generation of drug-eluting bioresorbable stents.

APT Pharmaceuticals, Inc. is developing pulmonary delivered drugs for respiratory diseases.

CoMentis is developing small molecule drugs for treating age-related macular degeneration (AMD), Alzheimer’s Disease and other cognitive disorders.

CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

EnteroMedics, Inc. is developing a medical device that treats obesity through modulation of vagus nerve activity.

Kereos, Inc. is developing imaging agents and therapeutic drugs for oncology and cardiovascular disease.

KFx Medical Corporation is developing a device system for repair of rotator cuff injuries.

Mirabilis Medica, Inc. is developing a HIFU-based system for the ablation of uterine fibroids.

Revascular Therapeutics, Inc. is developing a device system for treatment of total occlusions in the peripheral and coronary arteries.

XLumena is an endosurgery company developing novel medical devices that enable translumenal EUS therapy.